ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / SENS
ANGO (36) SGHT (39) DCTH (59) TCMD (67) ⌘ Pro Terminal →

Senseonics Holdings Inc. (SENS) — RQD Stock Rating Cockpit

$8.98 -5.57% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $8.87

Senseonics Holdings Inc. (SENS) carries a Roarable Rating of D- (Sell) with 40/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $502.8M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SENS Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SENS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Senseonics Holdings Inc. (NASDAQ: SENS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $8.98 (-5.57% 1D, market cap $502.8M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, SENS ranks #460 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SENS compare to ANGO and SGHT in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), SENS carries a Roarable D- (40/100 RQD), trailing P/E of N/A, gross margin of 44.7%, and ROIC of -35.0%. By comparison, ANGO (AngioDynamics Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M) and SGHT (Sight Sciences Inc.) posts a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $513.4M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SENS?
▼

Per SENS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001616543), Senseonics Holdings Inc. generated $35.3M in revenue (+56.9% YoY), -$69.1M in net income, and -$59.1M in free cash flow against $126.3M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $8.87 (-1.19%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.4% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510040
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Cash (6)Whales (15)SEC (8)Macro (8)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-8.1% Base Target
$11 Bull$8 Base$6 Bear
📬 FREE SENS RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SENS)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (40/100 Composite)
🔍 WHY SENS SCORES 40/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (38% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (20% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
32
Grade E$8.92-8% Next Q
Q2 (-2Q)
35
Grade E$8.21+1.5% Next Q
Q3 (-1Q)
37
Grade E$8.33+7.8% Next Q
Current
40
Grade D-$8.98-7.4% Hist 90D α
Trajectory: E (32) → D- (40)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SENS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SENS currently carries a cautious 40/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Big institutional funds and options desks are actively positioning on the bullish side.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.19) and Max Pain ($9.43) forces dealer call-delta covering toward $11.17.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SENS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SENS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 40%NO 60%Trade / Inspect Odds →
RSI-14 MOMENTUMBULLISH MOMENTUM
5730 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCORESOLID CORE (5–6)
5 / 99-Pt Accounting
52-WEEK LASER RANGE72% OF RANGE
L: $5$8.98H: $11
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 6 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 18 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 16 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on SENS

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (30)

-35.0% ROIC with 44.7% gross margin and -11.47% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (40)

Altman-Z 4.20 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (43)

18/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like SENS
  • ✓Big institutional funds and options desks are actively positioning on the bullish side.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SENS)

  • ✓Walkthrough of SENS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
SENS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +79.24%▲ ASCENDING CHANNEL
2026-11-03O $9.75H $9.75L $8.98C $8.98VOL 988.6K
RES: $11.24SUP: $7.51SMA50: $9.19SMA200: $7.22
$11.05$9.35$7.66$5.96$4.26RES $11.24SUP $7.51$8.982026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SENS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SENS Butterfly Map → + Track SENS →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +56.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on SENS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SENS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SENS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SENS)

Health Care Rank #460 of 1015 ⚔️ ANGO vs SENS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SENS vs. ANGO, SGHT, DCTH, TCMD)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Senseonics Holdings Inc. (SENS) ranks #460 by composite RQD confidence (40/100, grade D-) and #441 by equity capitalization ($502.8M). Within this direct 5-issuer industry benchmark cohort, TCMD leads on earnings valuation at 28.9x trailing P/E, while TCMD leads on capital efficiency and profitability with 17.1% ROIC and 75.9% gross margin. TCMD currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with SENS at 40/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
SENS ACTIVE
Senseonics Holdings Inc.
D- 40/100 — 44.7% -35.0% -5.57% $502.8M Benchmark Subject
ANGO
AngioDynamics Inc.
D- 36/100 — 54.6% -23.4% -1.92% $504.2M /ango-vs-sens →
SGHT
Sight Sciences Inc.
D- 39/100 — 86.2% -35.0% -1.82% $513.4M /sght-vs-sens →
DCTH
Delcath Systems Inc.
C- 59/100 — 86.2% 0.8% +1.78% $487.2M /dcth-vs-sens →
TCMD
Tactile Systems Technology Inc.
C+ 67/100 28.9x 75.9% 17.1% -0.74% $521.9M /tcmd-vs-sens →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001616543 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Senseonics Holdings Inc. (SENS) reported GAAP revenue of $35.3M (+56.9% vs. FY2024 revenue of $22.5M , and +57.5% cumulative change since FY2023) , GAAP net income of -$69.1M, operating cash flow of -$59.1M, and free cash flow of -$59.1M (+2.2% YoY). On the balance sheet, SENS closed FY2025 with $126.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $35.3M -$69.1M -$59.1M -$59.1M $126.3M —
FY2024 (FY) 2024-12-31 $22.5M -$78.6M -$60.5M -$60.5M $100.4M —
FY2023 (FY) 2023-12-31 $22.4M -$60.4M -$70.2M -$70.2M — —

3. SENS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SENS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Senseonics Holdings Inc. (NASDAQ: SENS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $8.98 (-5.57% 1D, market cap $502.8M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, SENS ranks #460 in composite RQD confidence.

How does SENS compare to ANGO and SGHT in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), SENS carries a Roarable D- (40/100 RQD), trailing P/E of N/A, gross margin of 44.7%, and ROIC of -35.0%. By comparison, ANGO (AngioDynamics Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M) and SGHT (Sight Sciences Inc.) posts a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $513.4M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SENS?

Per SENS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001616543), Senseonics Holdings Inc. generated $35.3M in revenue (+56.9% YoY), -$69.1M in net income, and -$59.1M in free cash flow against $126.3M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SENS trading relative to its 50-day, 200-day, and 52-week technical levels?

SENS last traded at $8.98 (-5.57% on volume of 573,531 shares), positioning the stock -2.29% below its 50-day simple moving average ($9.19) and +24.38% above its 200-day simple moving average ($7.22). Across its 52-week range of $4.79 to $10.64, SENS sits at the 71.6% percentile with a 14-day RSI of 57.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($7.86 to $10.10).

Direct Sub-Reports: SENS RQD Cockpit SENS 12M Forecast SENS Earnings & Move SENS Dividends & DRIP SENS Insiders & 13F SENS Whale Options SENS Profit Sankey SENS News & Why
ROARABLE RATING BRIEF • RQD 40/100 (D-) ✓ SEC XBRL & RQD VERIFIED

SENS — Senseonics Holdings Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Senseonics Holdings Inc. (SENS) earns a live Roarable RQD composite score of 40/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $8.98 (-5.57% 1D, market capitalization $502.8M).

  • Fundamental Cash Engine (6/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 44.7%, operating margin of -60.0%, and free cash flow yield of -11.47%.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Senseonics Holdings Inc. Is a NASDAQ-listed issuer in the Health Care sector, specifically Medical/Dental Instruments..5B. Per the market data, its gross margin is 44.7%, indicating that product-level economics are positive before operating costs..

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Senseonics Holdings Inc. (SENS) reported $35.3M in annual revenue (up from $22.5M in FY2024, +56.9% YoY) and -$69.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($22.4M revenue, -$60.4M net income) through FY2025, SENS scaled operating cash flow to -$59.1M and free cash flow to -$59.1M, backed by $126.3M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 40/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of -11.47% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 6/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $4.79 – $10.64 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream component suppliers, downstream distributors, and sector correlations therefore cannot be mapped from the source data.

  • Key Question #1: Can SENS sustain or expand its -60.0% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $35.3M and free cash flow of -$59.1M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is SENS's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

SENS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Senseonics Holdings Inc. (SENS) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to SENS Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SENS Bull vs. Bear Conversation Board — What's Your Call at $8.98?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SENS 🐻 33% BEARISH CONVICTION
1. Pick Your Side on SENS:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $11.22 (+18.0%)
📌 Pinned Debate

Institutional accumulation and options positioning score 15 of 20 and revenue grew from $22.4M in FY 2023 to $35.3M in FY 2025.

Here is why I am bullish on SENS here at $9.51: Institutional accumulation and options positioning score 15 of 20 and revenue grew from $22.4M in FY 2023 to $35.3M in FY 2025.. Compare SENS's -60.0% operating margin and -35.0% ROIC against the rest of Medical/Dental Instruments. As long as cash conversion holds up, dips toward $9.03 are getting bought.

VolSurface_Trader 🐂 BULL

Both sides have a point here — SENS's 8/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $7.70 (-19.0%)
Spot @ $9.51

Operating margin of -60% and ROIC of -35% with cash falling from $74.6M to $40.2M in one year signal an unsustainable burn.

Sitting on the sidelines or leaning short SENS above $9.51. Operating margin of -60% and ROIC of -35% with cash falling from $74.6M to $40.2M in one year signal an unsustainable burn.. Until Fundamental Cash Engine (6/20) and FCF yield (-11.47%) inflect higher, upside is capped near $10.64.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%